Biolab has a portfolio of more than 500 products, ranging from human line e animalin various areas of health.
We are a reference in Cardiology medicines, as well as having a significant presence in the areas of Gynecology, Dermatology, Pediatrics, Central Nervous System, Angiology, Orthopedics & Rheumatology, Dermocosmetics, among others.
in prescribing cardiology drugs
in terms of revenue.
Source (IQVIA NPS (MAT Apr 2024)
INTERNATIONAL OPERATIONS
We have already carried out more than 50 international partnerships, with the aim of bringing the world's most innovative therapeutic solutions to Brazil.
We also expanded our presence in Canada through the acquisition of Exzell Pharma.
INNOVATION
We are dedicated to the research, development, production and marketing of medicines, with the aim of contributing to the well-being and health of people, as well as dogs and cats.
With more than 400 patents filed, more than half of our turnover comes from innovative and exclusive products.
GENERICS
Being able to facilitate access to treatments with the same efficacy and excellence provided by therapies based on reference medicines is what motivates us to continue evolving and building new paths for health. Discover our range of generics.